ATE256675T1 - 5,6,7,8-tetrahydronaphto(2,3-b)furan- und indano(5,6-b)furan-amino-verbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen - Google Patents

5,6,7,8-tetrahydronaphto(2,3-b)furan- und indano(5,6-b)furan-amino-verbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE256675T1
ATE256675T1 AT96402044T AT96402044T ATE256675T1 AT E256675 T1 ATE256675 T1 AT E256675T1 AT 96402044 T AT96402044 T AT 96402044T AT 96402044 T AT96402044 T AT 96402044T AT E256675 T1 ATE256675 T1 AT E256675T1
Authority
AT
Austria
Prior art keywords
furan
tetrahydronaphto
indano
production
pharmaceutical compositions
Prior art date
Application number
AT96402044T
Other languages
English (en)
Inventor
Jean-Louis Peglion
Joel Vian
Aimee Dessinges
Mark Millan
Valerie Audinot
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE256675T1 publication Critical patent/ATE256675T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96402044T 1995-09-29 1996-09-26 5,6,7,8-tetrahydronaphto(2,3-b)furan- und indano(5,6-b)furan-amino-verbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen ATE256675T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9511446A FR2739379B1 (fr) 1995-09-29 1995-09-29 Nouveaux composes amines de 5,6,7,8-tetrahydronaphto(2,3-b) furane et d'indano(5,6-b)furane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ATE256675T1 true ATE256675T1 (de) 2004-01-15

Family

ID=9483043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96402044T ATE256675T1 (de) 1995-09-29 1996-09-26 5,6,7,8-tetrahydronaphto(2,3-b)furan- und indano(5,6-b)furan-amino-verbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen

Country Status (15)

Country Link
US (1) US5665765A (de)
EP (1) EP0765877B1 (de)
JP (1) JPH09110855A (de)
CN (1) CN1075067C (de)
AT (1) ATE256675T1 (de)
AU (1) AU707883B2 (de)
CA (1) CA2186337C (de)
DE (1) DE69631104T2 (de)
DK (1) DK0765877T3 (de)
ES (1) ES2213171T3 (de)
FR (1) FR2739379B1 (de)
NO (1) NO314501B1 (de)
NZ (1) NZ299465A (de)
PT (1) PT765877E (de)
ZA (1) ZA968167B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7216866B2 (en) * 2003-04-28 2007-05-15 Kyocera Mita Corporation Sheet transport path switching mechanism
CA3187217A1 (en) * 2020-08-06 2022-02-10 Matthew BAGGOTT 2-aminoindane compounds for mental disorders or enhancement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470990A (en) * 1983-03-14 1984-09-11 Ayerst, Mckenna & Harrison Inc. 6,7,8,9-Tetrahydronaphtho(1,2-B)furan-8-amine derivatives and their use as dopamine receptor stimulants
FR2613364B1 (fr) * 1987-04-01 1989-06-09 Adir Nouvelles amines tricycliques derivees du tetrahydro-5, 6, 7, 8 naphto (2, 3b) dihydro-2, 3 furanne, et du tetrahydro-6, 7, 8, 9 5h-benzocyclohepta (2, 3b) dihydro-2, 3 furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2613365B1 (fr) * 1987-04-01 1989-07-28 Adir Nouveaux derives de l'amino tetrahydro-5, 6, 7, 8 naphto (2, 3b) furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2725985B1 (fr) * 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ES2213171T3 (es) 2004-08-16
US5665765A (en) 1997-09-09
CN1150151A (zh) 1997-05-21
AU6589796A (en) 1997-04-10
NZ299465A (en) 1997-06-24
DK0765877T3 (da) 2004-04-19
DE69631104T2 (de) 2004-09-02
EP0765877B1 (de) 2003-12-17
DE69631104D1 (de) 2004-01-29
EP0765877A1 (de) 1997-04-02
CA2186337C (fr) 2002-01-01
NO964072D0 (no) 1996-09-27
FR2739379A1 (fr) 1997-04-04
CA2186337A1 (fr) 1997-03-30
FR2739379B1 (fr) 1997-10-24
NO964072L (no) 1997-04-01
CN1075067C (zh) 2001-11-21
AU707883B2 (en) 1999-07-22
PT765877E (pt) 2004-04-30
JPH09110855A (ja) 1997-04-28
ZA968167B (en) 1997-05-02
NO314501B1 (no) 2003-03-31

Similar Documents

Publication Publication Date Title
MX9203150A (es) Nuevos esteres de acidos tienilcarboxilicos de aminoalcoholes, sus productos de cuaternizacion y las composiciones farmaceuticas que los contienen.
ATE128458T1 (de) Naphtylalkylamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE50983T1 (de) Oberflaechenaktive n-(omega, omega-1-dialkoxy)und n-(omega, omega-1-dialkenoxy)-alk-1-yl-n,n,ntrisubstituierte ammoniumverbindungen, deren herstellung und sie enthaltende pharmazeutische formulierungen.
ATE89263T1 (de) Naphthalin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE8800207D0 (sv) Nya aminer, deras anvendning och framstellning
FR2678622B1 (fr) Nouveaux complexes de vanadium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2695387B1 (fr) Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ATE156829T1 (de) Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
PT99563A (pt) Processo para a preparacao de aminas biologicamente activas
FR2558837B1 (fr) Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant
ATE256675T1 (de) 5,6,7,8-tetrahydronaphto(2,3-b)furan- und indano(5,6-b)furan-amino-verbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ES2153457T3 (es) Amino-alquil-benzoxazolinonas y benzotiazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2091509T3 (es) Procedimiento para la obtencion de derivados de isopreno.
ES2130548T3 (es) Nuevos derivados alquil-amino-indanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2077473T3 (es) Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
FR2713644B1 (fr) Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ES2095714T3 (es) Nuevas amino-alquil-cromonas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen.
ATE112267T1 (de) Diacylglycerol-nicotinate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE101610T1 (de) Indol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE57913T1 (de) Catechinamide, verfahren zu ihrer herstellung, zwischenprodukte und pharmazeutische zubereitung.
ATE23859T1 (de) Pharmazeutische benzodioxinverbindungen und verfahren zu deren herstellung.
ES2091670T3 (es) Nuevos derivados (ciclohexil)-alquenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
FR2691967B1 (fr) Nouveaux composes pyrrolothienopyraziniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0765877

Country of ref document: EP

REN Ceased due to non-payment of the annual fee